Stocks and InvestingStocks and Investing
Thu, November 1, 2018
Wed, October 31, 2018
Tue, October 30, 2018
Mon, October 29, 2018
Fri, October 26, 2018

Laura Chico Maintained (BMRN) at Buy with Increased Target to $114 on, Oct 26th, 2018


Published on 2024-10-26 09:57:24 - WOPRAI, Laura Chico
  Print publication without navigation


Laura Chico of Raymond James, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $113 to $114 on, Oct 26th, 2018.

Laura has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 1 agrees with Laura's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $98 on, Monday, August 6th, 2018


These are the ratings of the 7 analyists that currently disagree with Laura


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $116 on, Tuesday, October 23rd, 2018
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $126 on, Monday, October 1st, 2018
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $120 on, Thursday, August 9th, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $120 on, Monday, August 6th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $115 on, Friday, August 3rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $109 on, Friday, August 3rd, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018